Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

Bath & Body Works (NYSE:BBWI) had its price target boosted by research analysts at JPMorgan Chase & Co. from $35.00 to $39.00 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 8.57% from the stock’s previous close.

Several other equities research analysts have also recently weighed in on the stock. UBS Group cut their price objective on shares of Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, August 29th. Piper Sandler increased their price target on shares of Bath & Body Works from $35.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. Telsey Advisory Group restated an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a research note on Monday. Finally, Raymond James decreased their price target on Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating on the stock in a research note on Thursday, August 29th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Trading Up 2.0 %

Shares of BBWI stock opened at $35.92 on Tuesday. The stock has a market cap of $7.87 billion, a P/E ratio of 8.83, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79. Bath & Body Works has a 1 year low of $26.20 and a 1 year high of $52.99. The stock has a 50 day simple moving average of $30.81 and a 200 day simple moving average of $35.65.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Analysts forecast that Bath & Body Works will post 3.18 EPS for the current year.

Insider Activity

In other Bath & Body Works news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction on Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares of the company’s stock, valued at $7,202,134.68. The trade was a 2.53 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.27% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently modified their holdings of the business. California State Teachers Retirement System raised its position in Bath & Body Works by 1.4% during the 1st quarter. California State Teachers Retirement System now owns 345,749 shares of the company’s stock worth $17,294,000 after purchasing an additional 4,695 shares during the last quarter. Tidal Investments LLC lifted its stake in shares of Bath & Body Works by 223.9% in the first quarter. Tidal Investments LLC now owns 19,398 shares of the company’s stock worth $970,000 after acquiring an additional 13,410 shares during the period. Atria Investments Inc bought a new stake in Bath & Body Works in the first quarter valued at approximately $1,058,000. Northwest Bank & Trust Co increased its position in Bath & Body Works by 2.5% during the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock valued at $655,000 after purchasing an additional 315 shares during the period. Finally, DekaBank Deutsche Girozentrale increased its position in Bath & Body Works by 1.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock valued at $1,560,000 after purchasing an additional 322 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.